Lexicon Pharmaceuticals
LXRX
#7142
Rank
S$0.65 B
Marketcap
S$1.81
Share price
-1.41%
Change (1 day)
108.52%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : S$0.15 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has S$0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.32 B44.04%
2023-12-31S$0.22 B21.07%
2022-12-31S$0.18 B58.17%
2021-12-31S$0.11 B-41.79%
2020-12-31S$0.20 B-45%
2019-12-31S$0.36 B67.5%
2018-12-31S$0.21 B-47.4%
2017-12-31S$0.41 B-17.11%
2016-12-31S$0.50 B-32%
2015-12-31S$0.73 B64.47%
2014-12-31S$0.44 B174.07%
2013-12-31S$0.16 B-40.06%
2012-12-31S$0.27 B-25.18%
2011-12-31S$0.36 B34.15%
2010-12-31S$0.27 B19.19%
2009-12-31S$0.22 B54.72%
2008-12-31S$0.14 B-60.4%
2007-12-31S$0.37 B203.56%
2006-12-31S$0.12 B-26.1%
2005-12-31S$0.16 B16.21%
2004-12-31S$0.14 B-19.19%
2003-12-31S$0.17 B8.83%
2002-12-31S$0.16 B-41.41%
2001-12-31S$0.27 B-21.08%
2000-12-31S$0.35 B2203.98%
1999-12-31S$15.24 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
S$3.94 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$10.94 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$0.55 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.91 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$4.59 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.11 B-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.65 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.87 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.22 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA